Wings has recognised the reality on the basis of various realistic statistics which reflect that India is very soon going to be a Diabetes, Hypertension, Obesity capital of the world, yielding maximum detriment to countless lives in the coming years. Ironically, these diseases together have gained an epithet ‘Lifestyle Diseases’ (Metabolistic diseases – to be specific, technically). There will be an enormous need for drugs to manage the disorders like Diabetes, Hypertension, Dyslipidemia and increasing co-morbidities – complications and non-compliance at large. Apparently, Wings has introduced Metabolic Care as a division that has splurged into the Prescriptions and Branded Formulations segments, offering drugs to counter the disorders to a great extent.